Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform

BACKGROUND: Breast cancer is the most common invasive cancer among women. Currently, there are only a few models used for therapy selection, and they are often poor predictors of therapeutic response or take months to set up and assay. In this report, we introduce a microfluidic OrganoPlate® platfor...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Cancer
Auteurs principaux: Lanz, Henriette L., Saleh, Anthony, Kramer, Bart, Cairns, Junmei, Ng, Chee Ping, Yu, Jia, Trietsch, Sebastiaan J., Hankemeier, Thomas, Joore, Jos, Vulto, Paul, Weinshilboum, Richard, Wang, Liewei
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2017
Sujets:
Technical Advance
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5668957/
https://ncbi.nlm.nih.gov/pubmed/29096610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3709-3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires